|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affectsOrgan
|
liver
|
|
gptkbp:canBeAsymptomatic
|
true
|
|
gptkbp:canBeCoinfectedWith
|
gptkb:Hepatitis_D_virus
gptkb:HIV
gptkb:Hepatitis_C_virus
|
|
gptkbp:canBeVerticalTransmission
|
true
|
|
gptkbp:cause
|
liver transplantation
|
|
gptkbp:causedBy
|
gptkb:Hepatitis_B_virus
|
|
gptkbp:chronicityDefinition
|
infection lasting more than 6 months
|
|
gptkbp:complication
|
cirrhosis
liver failure
hepatocellular carcinoma
|
|
gptkbp:diagnosedBy
|
gptkb:HBV_DNA_test
gptkb:HBsAg_test
liver function test
|
|
gptkbp:guidanceSystem
|
gptkb:American_Association_for_the_Study_of_Liver_Diseases
gptkb:World_Health_Organization
gptkb:European_Association_for_the_Study_of_the_Liver
|
|
gptkbp:hasBiomarker
|
gptkb:HBsAg
gptkb:HBeAg
gptkb:HBV_DNA
|
|
gptkbp:hasScreeningRecommendation
|
pregnant women
blood donors
high-risk populations
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Chronic Hepatitis B
|
|
gptkbp:ICD-10_code
|
B18.1
|
|
gptkbp:prevalence
|
over 250 million people worldwide
|
|
gptkbp:prevention
|
gptkb:Hepatitis_B_vaccine
safe injection practices
screening blood products
safe sex
|
|
gptkbp:riskFactor
|
unprotected sex
injection drug use
healthcare work
birth in endemic area
|
|
gptkbp:symptom
|
nausea
abdominal pain
fatigue
jaundice
loss of appetite
|
|
gptkbp:transmissionRoute
|
blood
sexual contact
perinatal
|
|
gptkbp:treatment
|
gptkb:insulin
gptkb:entecavir
antiviral drug
tenofovir
|
|
gptkbp:bfsParent
|
gptkb:CHB
gptkb:Liver_Tumors
|
|
gptkbp:bfsLayer
|
7
|